Anaplerotic Therapy Using Triheptanoin for Patients With Glycogen Storage Disease Type I
Condition(s):Glycogen Storage Disease Type ILast Updated:November 13, 2020Recruiting
Hide Studies Not Open or Pending
Condition(s):Glycogen Storage Disease Type ILast Updated:November 13, 2020Recruiting
Condition(s):Glycogen Storage Disorder Type 1; Hypoglycemia; Cornstarch; GlycosadeLast Updated:August 3, 2017Completed
Condition(s):Patient Compliance; HealthyLast Updated:August 22, 2019Recruiting
Condition(s):Glycogen Storage Disease Type ILast Updated:February 17, 2020Active, not recruiting
Condition(s):Glycogen Storage Disease Type I; Glucose 6 Phosphatase DeficiencyLast Updated:October 28, 2019Recruiting
Condition(s):Glycogen Storage Disease Type IA; Von Gierke’s Disease (GSD Type Ia)Last Updated:January 19, 2021Enrolling by invitation
Condition(s):Glycogen Storage Disease Type IALast Updated:January 13, 2021Enrolling by invitation
Condition(s):Glycogen Storage Disease Type 1 (GSD 1)Last Updated:March 23, 2015Completed
Condition(s):Glycogen Storage Disease Type IALast Updated:October 30, 2020Recruiting
Condition(s):Fructose Metabolism, Inborn Errors; Glycogen Storage Disease; Glycogen Storage Disease Type I; Glycogen Storage Disease Type II; Glycogen Storage Disease Type III; Glycogen Storage Disease Type IV; Glycogen Storage Disease Type V; Glycogen Storage Disease Type VI; Glycogen Storage Disease Type VII; Glycogen Storage Disease Type VIIILast Updated:April 3, 2020Active, not recruiting
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.